Ebastine/Pseudoephedrine Hydrochloride

依巴斯汀/盐酸伪麻黄碱

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEbastine/Pseudoephedrine Hydrochloride

Drug Alias Name盐酸伪麻黄碱/依巴斯汀Pseudoephedrine Hydrochloride and EbastineEbastine and Pseudoephedrine HydrochloridePseudoephedrine Hydrochloride/EbastinePseudoephedrine/ebastine +[7]

ClassificationSmall molecules

Mechanisms of ActionHistamine H1 receptor antagonistsAlpha adrenergic receptor agonists

TargetsHistamine H1 receptorAlpha adrenergic receptor

Therapy Area/IndicationsRhinitis, Allergic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Pseudoephedrine Hydrochloride Ebastine

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesAlmirall Sa

China Registration ClassN/A

Develop Information

Active CompaniesAlmirall Sa

Inactive CompaniesN/A

Active IndicationsRhinitis, Allergic

Inactive IndicationsN/A

Other Information

ATC CodeR01BA52